1. Systematic Evaluation of Fluorination as Modification for Peptide-based Fusion Inhibitors against HIV-1 Infection. Huhmann, S., E.K. Nyakatura, A. Rohrhofer, J. Moschner, B. Schmidt, J. Eichler, C. Roth, and B. Koksch. ChemBioChem, 2021. 22(24): p. 3443-3451. PMID[34605595].
[PubMed]. HIV_12_2021.
2. Investigation of HIV-1 Viral Protein R Inhibitory Activities of Twelve Thai Medicinal Plants and Their Commercially Available Major Constituents. Jaisi, A., Prema, S. Madla, Y.E. Lee, A. Septama, and H. Morita. Chemistry & Biodiversity, 2021. 18(12): e2100540. PMID[34599555].
[PubMed]. HIV_12_2021.
3. Design of the naphthyl-Diarylpyrimidines as Potent Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS) via Structure-based Extension into the Entrance Channel. Jin, X., H.R. Piao, C. Pannecouque, E. De Clercq, C. Zhuang, and F.E. Chen. European Journal of Medicinal Chemistry, 2021. 226: 113868. PMID[34583311].
[PubMed]. HIV_12_2021.
4. Biological Investigation of Amaryllidaceae Alkaloid Extracts from the Bulbs of Pancratium trianthum Collected in the Senegalese Flora. Ka, S., N. Mérindol, I. Seck, S. Ricard, A. Diop, C.S.B. Boye, K. Landelouci, B. Daoust, L. Berthoux, G. Pépin, M. Seck, and I. Desgagné-Penix. Molecules, 2021. 26(23): 7382. PMID[34885964]. PMCID[PMC8659059].
[PubMed]. HIV_12_2021.
5. Discovery, Optimization, and Target Identification of Novel Coumarin Derivatives as HIV-1 Reverse Transcriptase-associated Ribonuclease H Inhibitors. Kang, D., Ç. Urhan, F. Wei, E. Frutos-Beltrán, L. Sun, M. Álvarez, D. Feng, Y. Tao, C. Pannecouque, E. De Clercq, L. Menéndez-Arias, X. Liu, and P. Zhan. European Journal of Medicinal Chemistry, 2021. 225: p. 113769. PMID[34403976].
[PubMed]. HIV_12_2021.
6. Histone deacetylase Inhibition Reduces Deleterious Cytokine Release Induced by Ingenol Stimulation. Larragoite, E.T., R.A. Nell, L.J. Martins, L.R. Barrows, V. Planelles, and A.M. Spivak. Biochemical Pharmacology, 2022. 195: 114844. PMID[34801521]. PMCID[PMC8712404].
[PubMed]. HIV_12_2021.
7. Clausanisumine, a Prenylated Bicarbazole Alkaloid from the Fruits of Clausena anisum-olens and Its Potential anti-HIV Activity. Liu, Y.P., J.M. Guo, Z. Xie, X.Y. Suo, Z.Y. Liu, Z.H. Qiao, R.Q. Guan, Y. Bian, L. Qiang, and Y.H. Fu. The Journal of Organic Chemistry, 2021. 86(24): p. 17722-17726. PMID[34817178].
[PubMed]. HIV_12_2021.
8. Artapilosines A and B, Unusual Phenanthrene Derivatives Related to Aporphine Alkaloids from Artabotrys pilosus. Liu, Y.P., T.W. Wang, Z. Xie, Y. Bian, Y.Y. Liu, R.Q. Guan, Z.Y. Liu, L. Qiang, G.Y. Chen, and Y.H. Fu. Journal of Natural Products, 2021. 84(12): p. 3117-3121. PMID[34812640].
[PubMed]. HIV_12_2021.
9.Synthesis and Crystal Structure of 6-Cyclohexyl-8-methylphenanthridine. Luo, Z.G., D.D. Wei, C.T. Peng, C.F. Liu, Q.H. Chen, R.H. Zhang, and X.M. Xu. Chinese Journal of Structural Chemistry, 2021. 40(10): p. 1284-1290. PMID[000716525700005].
[WOS]. HIV_12_2021.
10. Design, Synthesis, and Antiviral Activity of 1,2,3,4-Tetrahydropyrimidine Derivatives Acting as Novel Entry Inhibitors to Target at "Phe43 Cavity" of HIV-1 gp120. Senapathi, J., A. Bommakanti, V. Kusuma, S. Vangara, and A.K. Kondapi. Bioorganic & Medicinal Chemistry, 2021. 52: 116526. PMID[34839157].
[PubMed]. HIV_12_2021.
11. HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of Curcuma aeruginosa Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and in Silico Screening. Sillapachaiyaporn, C., P. Rangsinth, S. Nilkhet, N. Moungkote, and S. Chuchawankul. Pharmaceuticals, 2021. 14(11): 1115. PMID[34832897]. PMCID[PMC8621417].
[PubMed]. HIV_12_2021.
12. A Plant-biotechnology Approach for Producing Highly Potent anti-HIV Antibodies for Antiretroviral Therapy Consideration. Singh, A.A., P. Pillay, L. Kwezi, and T.L. Tsekoa. Journal of Genetic Engineering and Biotechnology, 2021. 19(1): 180. PMID[34878628]. PMCID[PMC8655037].
[PubMed]. HIV_12_2021.
13. INSTIs and NNRTIs Potently Inhibit HIV-1 Polypurine Tract Mutants in a Single Round Infection Assay. Smith, S.J., A. Ferris, X. Zhao, G. Pauly, J.P. Schneider, T.R. Burke, Jr., and S.H. Hughes. Viruses, 2021. 13(12): 2501. PMID[34960770]. PMCID[PMC8705849].
[PubMed]. HIV_12_2021.
14. Indolylarylsulfones Bearing Phenylboronic acid and Phenylboronate ester Functionalities as Potent HIV‑1 Non-Nucleoside Reverse Transcriptase Inhibitors. Xu, S., S. Song, L. Sun, P. Gao, S. Gao, Y. Ma, D. Kang, Y. Cheng, X. Zhang, S. Cherukupalli, E. De Clercq, C. Pannecouque, X. Liu, and P. Zhan. Bioorganic & Medicinal Chemistry, 2022. 53: 116531. PMID[34890994].
[PubMed]. HIV_12_2021.
15. Design, Synthesis, and Mechanism Study of Dimerized Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors. Zhang, X., L. Sun, M.E. Meuser, W.A. Zalloum, S. Xu, T. Huang, S. Cherukupalli, X. Jiang, X. Ding, Y. Tao, D. Kang, E. De Clercq, C. Pannecouque, A. Dick, S. Cocklin, X. Liu, and P. Zhan. European Journal of Medicinal Chemistry, 2021. 226: p. 113848. PMID[34592608].
[PubMed]. HIV_12_2021.
Patent Citations
16. Synthesis of bis-THF Activated Antiviral Compounds Treating HIV or HTLV Infections. Schiffer, C.A., A. Ali, N. Kurt-Yilmaz, L.N. Rusere, G.J. Lockbaum, and M. Henes. Patent. 2021. 2021-17334454 20210371439: 66pp.
[Patent]. HIV_12_2021.